yasuh
ro
kato
yatsugi
noda
masashi
unoura
nobuyoshi
tanaka
kenichi
kobayashi
nobu
hattori
kiichi
hatano
shigeyasu
kobayashi
liver
tissu
develop
liver
cell
necrosi
prolong
surviv
atso
found
earlier
mous
interferon
administ
greater
prolong
surviv
patic
necrosi
present
studi
investig
effect
exogen
mous
interferon
fulmin
hepat
mous
model
growth
quantit
determin
growth
delay
brain
tumor
dbt
cell
deriv
mous
brain
tumor
use
cultur
medium
minimum
essenti
medium
mem
fluid
supplement
calf
serum
tryptos
broth
cultur
medium
discard
dbt
cell
becam
monolay
cultur
dish
cell
cultur
ml
crude
suspens
c
hr
thereaft
dbt
cell
infect
cultur
ml
cultur
medium
hr
five
millilit
cultur
broth
thu
obtain
frozen
store
c
use
experi
quantit
accord
method
hirano
et
al
dbt
cell
monolayerd
petri
dish
mm
diamet
infect
ml
store
cultur
broth
liver
homogen
c
min
dbt
cell
wash
fresh
cultur
broth
cultur
medium
contain
nobel
agar
day
cultur
number
plaqu
form
count
administr
mous
interferon
highli
purifi
mous
interferon
contain
orand
use
experi
provid
toray
basic
research
laboratori
kamakura
japan
prepar
mous
lcell
specif
activ
iumg
protein
dissolv
physiolog
salin
adjust
concentr
ml
mice
given
interferon
divid
four
group
base
time
inocul
group
one
day
inocul
group
time
inocul
group
one
day
inocul
group
two
day
inocul
group
iumouseday
exogen
mous
interferon
administ
intraperiton
day
inocul
treatment
given
control
group
c
inocul
dosag
interferon
iumouseday
use
experi
use
levin
hahn
calcul
weightconvers
basi
correspond
sever
million
unitsday
man
liver
histolog
quantit
hepat
tissu
three
anim
group
c
control
sacrif
dalli
third
day
inocul
liver
section
stain
hematoxylin
eosin
studi
light
microscopi
mice
die
studi
liver
histolog
examin
immedi
addit
amount
hepat
tissu
one
anim
group
determin
correl
light
microscop
find
count
determin
plaqueassay
method
describ
homogen
microscop
histolog
liver
group
c
control
spotti
necrosi
observ
liver
one
three
anim
one
day
inocul
submass
hepat
necrosi
seen
three
anim
second
day
massiv
necrosi
three
anim
third
day
group
necrosi
hepat
cell
one
day
inocul
spotti
necrosi
found
one
three
anim
second
day
third
day
focal
necrosi
seen
two
three
anim
submass
necrosi
one
group
degre
necrosi
hepat
cell
examin
time
milder
compar
group
c
count
hepat
tissu
liver
histolog
group
c
count
hepat
tissu
one
day
inocul
x
pfug
wet
tissu
x
pfug
wet
tissu
second
day
figur
necrosi
hepat
cell
progress
spotti
necrosi
day
submass
necrosi
day
grew
liver
group
count
hepat
tissu
one
day
inocul
pfug
wet
tissu
pfug
wet
tissu
second
day
necrosi
day
focal
necrosi
day
grow
liver
surviv
time
death
occur
group
c
n
begin
second
day
inocul
anim
die
third
day
contrast
group
n
die
four
six
day
inocul
three
still
aliv
seven
day
group
n
one
live
seven
day
die
day
group
n
none
live
seven
day
die
day
day
group
n
six
live
four
day
analyz
cumul
surviv
rate
surviv
group
found
significantli
prolong
compar
control
p
figur
virelizi
gresser
inocul
mice
produc
chronic
hepat
semiresist
anim
mous
antiinterferon
antibodi
administ
mice
start
shortli
inocul
develop
fulmin
hepat
die
observ
suggest
interferon
system
import
role
vivo
defens
mechan
mhvhepat
hand
accord
report
schindler
et
al
serum
interferon
level
increas
significantli
inocul
mice
suscept
die
fulmin
hepat
infect
wherea
aj
mice
resist
develop
fulmin
hepat
increas
serum
interferon
insignific
conclud
interferon
system
seem
import
defens
mechan
vivo
thu
establish
opinion
interferon
system
involv
mhv
hepat
progress
report
assess
effect
exogen
mous
interferon
mhv
hepat
present
studi
investig
effect
exogen
mous
produc
mous
l
cell
murin
fulmin
hepat
model
effect
assess
histolog
chang
liver
content
hepat
tissu
surviv
time
degre
hepat
cell
necrosi
comparison
control
group
much
milder
histolog
group
mous
interferon
administ
time
inocul
indic
administr
mous
interferon
dose
similar
use
man
without
side
effect
suppress
progress
hepat
cell
necrosi
murin
model
mechan
hepat
cell
necrosi
mhv
recogn
involv
hostrespons
mechan
direct
viral
cytopatholog
sinc
count
hepat
tissu
remark
lower
group
control
group
time
measur
exogen
mous
may
suppress
hepat
cell
necrosi
group
direct
antivir
action
andor
interferondepend
immun
respons
natur
killer
cell
cytotox
cell
macrophag
etc
activ
macrophag
genet
restrict
mice
wide
accept
import
defens
mechan
infect
bang
et
al
report
grew
well
cultur
macrophag
taken
liver
peritoneum
icr
mice
wherea
growth
observ
similar
system
use
macrophag
resist
regard
specul
exogen
mous
might
enhanc
antivir
activ
macrophag
suscept
icr
mice
surviv
time
significantli
prolong
group
mous
interferon
start
mice
develop
fulmin
hepat
even
group
administr
interferon
start
mice
alreadi
die
surviv
time
somewhat
prolong
compar
control
observ
clearli
demonstr
valu
earli
treatment
mous
interferon
produc
mous
l
cell
murin
model
fulmin
hepat
although
relev
find
human
fulmin
hepat
caus
differ
virus
unclear
